Welcome to LookChem.com Sign In|Join Free
  • or
Methanone, (2-amino-5-chloro-3-pyridinyl)phenyl- is a chemical with a specific purpose. Lookchem provides you with multiple data and supplier information of this chemical.

628300-57-2

Post Buying Request

628300-57-2 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

628300-57-2 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 628300-57-2 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 6,2,8,3,0 and 0 respectively; the second part has 2 digits, 5 and 7 respectively.
Calculate Digit Verification of CAS Registry Number 628300-57:
(8*6)+(7*2)+(6*8)+(5*3)+(4*0)+(3*0)+(2*5)+(1*7)=142
142 % 10 = 2
So 628300-57-2 is a valid CAS Registry Number.

628300-57-2Downstream Products

628300-57-2Relevant academic research and scientific papers

METHODS AND COMPOSITIONS FOR INHIBITION OF BROMODOMAIN-CONTAINING PROTEINS

-

Page/Page column 78, (2014/10/15)

The present invention relates to compounds that bind to and otherwise modulate the activity of bromodomain-containing proteins, to processes for preparing these compounds, to pharmaceutical compositions containing these compounds, and to methods of using these compounds for treating a wide variety of conditions and disorders.

Synthesis and evaluation of novel 3,4,6-substituted 2-quinolones as FMS kinase inhibitors

Wall, Mark J.,Chen, Jinsheng,Meegalla, Sanath,Ballentine, Shelley K.,Wilson, Kenneth J.,DesJarlais, Renee L.,Schubert, Carsten,Chaikin, Margery A.,Crysler, Carl,Petrounia, Ioanna P.,Donatelli, Robert R.,Yurkow, Edward J.,Boczon, Lisa,Mazzulla, Marie,Player, Mark R.,Patch, Raymond J.,Manthey, Carl L.,Molloy, Christopher,Tomczuk, Bruce,Illig, Carl R.

, p. 2097 - 2102 (2008/12/21)

A series of 3,4,6-substituted 2-quinolones has been synthesized and evaluated as inhibitors of the kinase domain of macrophage colony-stimulating factor-1 receptor (FMS). The fully optimized compound, 4-(4-ethyl-phenyl)-3-(2-methyl-3H-imidazol-4-yl)-2-qui

QUINOLINONE DERIVATIVES AS INHIBITORS OF C-FMS KINASE

-

Page/Page column 27, (2010/02/10)

The invention is directed to compounds of Formulae I and II: (I) (II) wherein R1, R2, R3, R5, R6, Y1, Y2, Y3, Y4 and X are set forth in the specification, as well as solvates, hydrates, tautomers or pharmaceutically acceptable salts thereof, that inhibit protein tyrosine kinases, especially c-fms kinase.

CCR9 INHIBITORS AND METHODS OF USE THEREOF

-

Page 68, (2008/06/13)

The invention relates to compounds represented by Structural Formula I, which can bind to CCR9 receptors and block the binding of a ligand (e.g., TECK) to the receptors. The invention also relates to a method of inhibiting a function of CCR9, and to the use compounds represented by Structural Formula I in research, therapeutic, prophylactic and diagnostic methods.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 628300-57-2